• UTMB Team Proves Potential for Reducing Pre-Term Birth by Treating Fetus as Patient

    The results of a study by researchers at the University of Texas Medical Branch may pave the way for a new medicine delivery system that could reduce the incidence of pre-term labor and premature birth by allowing physicians to treat the ‘fetus as the patient’. The study has been published in Science Advances.

  • close up of a COVID-19 spike

    Benefits outweigh risks of COVID-19 vaccines

    Texans are lining up to receive their COVID-19 vaccine and many more are patiently waiting their turn. The good news is that while COVID-19 can be life-threatening, the only medical risk to vaccination is for those with a history of allergic reactions to these vaccines or their ingredients.

  • breastfeeding mother and child

    Breast milk can be powerful, but can it stop the new coronavirus?

    There is a lot we do not know about SARS-CoV-2, the virus that causes COVID-19, including how it may interact with human milk. However, researchers at the University of Texas Medical Branch are trying to figure out if breast milk has any innate ability to stop the spread of the virus that causes COVID-19, or if an infected mother can pass antibodies to her breastfeeding child.

  • close up of a COVID-19 spike

    Which COVID-19 vaccine should you get?

    In front of the press, President-elect Joe Biden rolled up his sleeve for the Pfizer vaccine and Dr. Anthony Fauci for the Moderna vaccine. While some tried to read something into their choices, these vaccination events were likely arranged to instill public trust in both vaccines. Regardless, the public wants to know which vaccine is best.

  • Covid virus image

    UTMB researchers find Pfizer vaccine effective against new COVID-19 strain

    A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown that the common mutation N501Y from the newly emerged SRAS-CoV-2 strains does not compromise Pfizer’s COVID-19 vaccine. This is the first study to investigate if the fast-spreading new virus strains affects the vaccine’s effectiveness. The study is currently available in bioRxiv (https://doi.org/10.1101/2021.01.07.425740).

  • close up of a COVID-19 spike

    When will it be my turn to get the COVID-19 vaccine?

    It’s music to many physicians’ ears to hear people clamoring for their COVID-19 vaccine. The virus has damaged the economy and taken far too many lives. A year ago, it was unbelievable that effective, safe vaccines could be delivered in less than a year from the first identification of a new pathogen.

  • close up of a COVID-19 spike

    Here are some answers about new COVID-19 vaccines

    Two COVID-19 vaccines have received Emergency Use Authorization in the United States. They’re commonly referred to as the Pfizer and Moderna vaccines. Both are messenger RNA (mRNA) vaccines and use a technology developed over the last decade.

Categories